|
May 15
|
Trevena Reports First Quarter 2024 Results and Provides Business Update
|
|
Apr 1
|
Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update
|
|
Dec 28
|
Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise
|
|
Dec 27
|
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise
|
|
Dec 4
|
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting
|
|
Dec 4
|
Trevena Awarded OLINVYK Agreement with Premier, Inc.
|
|
Nov 30
|
Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries
|
|
Jun 26
|
Trevena Announces New Topline OLINVYK Data Highlighting Reduced Cost per Admission from ARTEMIS Real-World Outcomes Study
|